product Name：Verapamil hydrochloride
  • alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-; benzeneacetonitrile hydrochloride; 5-[(3,4-DIMETHOXYPHENETHYL)METHYLAMINO]-2-(3,4-dimethoxyphenyl)-2-ISOPROPYL-VALERONITRILE HYDROCHLORIDE; CALAN; IPROVERATRIL; ISOPTIN; (+/-)-5-[N-(3,4-dimethoxyphenylethyl)-METHYLAMINO]-2-(3,4-dimethoxyphenyl)-2-ISOPROPYLVALERONITRILE HYDROCHLORIDE; 5-[N-(3,4-dimethoxyphenylethyl)METHYLAMINO]-2-(3,4-dimethoxyphenyl)-2-ISOPROPYLVALERONITRILE HYDROCHLORIDE; alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-benzeneacetonitrile hydrochloride; ALPHA-[3-[[2-(3,4-DIMETHOXYPHENYL)ETHYL]METHYLAMINO]PROPYL]-3,4-DIMETHOXY-ALPHA-(1-METHYLETHYL)BENZENEACETONITRILE HYDROCHLORIDE; Verapamil HCl; finoptin; iproveratrilhydrochloride; izoptinhydrochloride; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile hydrochloride (1:1); (+/-)-Verapamil hydrochloride; (+/-)-Verapamil Hydrochloride
  • 23313-68-0;152-11-4
  • 205-800-5
  • C27H39ClN2O4
  • 491.0626
  • InChI=1/C27H38N2O4.ClH/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6;/h9-12,17-18,20H,8,13-16H2,1-7H3;1H
  • Verapamil hydrochloride 23313-68-0;152-11-4
  • 140-144℃
  • 586.1°C at 760 mmHg
  • 308.3°C
  • soluble
  • 1.01E-13mmHg at 25°C
  •  T:Toxic;
  • R23/24/25:;
  • S36/37/39:;
    S45:;